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The growing spectre of human
reproductive cloning is putting
unprecedented strain on some of
the legislative bodies in Europe
trying to keep a grip on it and the
future of embryonic stem cell
research.
In Britain, which has gone further
than many countries with detailed
legislation to permit research on
embryonic stem cells, a group of
opponents late last year challenged
the legislation, saying that it did not
prevent human cloning. A senior
British judge ruled that the law as it
stood did not govern the latest
scientific techniques, through
which researchers can create a
human embryo using a type of
cloning rather than using human
sperm. This meant the government
technically had no control over
stem cell research from such
embryos. “The Human Fertilisation
and Embryology Authority has no
power to stop this research. The
law as it stands is hopeless and we
are glad we have shown the
government lie that human cloning
is prohibited,” said Bruno
Quintavalle, director of the Pro Life
Alliance, which brough the case to
court.
Just 11 days after the court
ruling, the government moved to
rush emergency legislation
through both houses of parliament
to prevent an outbreak of
unregulated embryo research in
Britain by any maverick scientists
wanting to clone human beings.
Ministers will legislate again to
clear up confusion, the health
minister Lord Hunt, told members
of the House of Lords, some of
whom complained of hasty and
unwise action in a field where
earlier laws have already proved
ineffectual in the face of scientific
advance. “To make legislation on
the hoof may not be the best way
of dealing with things,” said Lord
Alton, one vocal pro-life peer.
The mood of urgency —
ministers did not even wait for the
appeal against the high court
ruling — was strengthened by the
news that a private biotech firm in
Massachusetts had managed to
clone a human embryo using the
same technique developed by
Edinburgh scientists to clone Dolly
the sheep. It did so for therapeutic
purposes only, the US firm
stressed. But the claims by
Severino Antinori, the Italian
fertility doctor, and similar people
in the US, that they have 200
women eager for cloned babies
has alarmed authorities around
the world.
Further worries for the British
goverment were raised last month.
In an interview last month with
Britain’s Observer newspaper,
Antinori said how much he would
like to carry out his work in
England. “It is where the great
advances have come from. It is
the natural place,” he said.
Like most House of Lords
members who spoke in the hastily
called debate of the new bill to
ban the implantation of stem cell-
derived  embryos inside a
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Flags of confusion: the Brussels home
of the European parliament saw
members late last year reject their own
report on the ethical, legal, economic
and social implications of human genet-
ics. Some members now believe that
such big moral and ethical issues are
better handled at the level of member
states of the Union but others still wish to
develop a pan-European Union position.
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woman’s uterus, Lord Winston, a
clinician working in reproductive
medicine, endorsed the “untold
benefits to many thousands”
which would eventually result
from therapeutic cloning. The
Oxford academic, Lady Warnock,
whose commission led to the
1990 Human Fertilisation and
Embryology Act, also welcomed
the bill because it would end what
critics called the “slippery slope
argument” by defining more
precisely in statute what an
embryo was.
Two days later, the government
forced through the bill, devoting
just over three hours to its second
reading, committee stage, report
and third reading, a process
which usually takes several
months. It’s “panic legislation,
contemptuous of parliament and
an insult to the house and to
voters,” Sir Patrick Cormack said.
“I do now worry about the future
of parliamentary democracy,”
Paul Marsden said.
But the government faces
further worries. The Egyptian
gynaecologist, Mohammed
Taranassi, who works in London
and has one of the country’s
highest success rates with in vitro
fertilisation techniques, is
planning to extend treatments to
include the creation of embryos
able to provide donor material for
siblings with genetic diseases.
Taranassi hopes to get a licence
to go ahead but if not, he believes
a loophole in the law may allow
him to set up anyway. Lord
Winston, who helped develop
embryo screening techniques,
told a television programme that a
line must be drawn here. “It really
troubles me that some of my
colleagues are prepared to
consider a child as a commodity.”
Concerns about human cloning
prompted the European
parliament to set up a special
committee to look into the ethical,
legal, economic and social
implications of human genetics in
January last year. For the
European Parliament the whole
exercise has, however, proved a
considerable embarrassment. The
committee spent 11 months
consulting scientists on both
sides of the argument, but right-
wing members of the European
parliament (MEPs), Christian
Democrats and Greens combined
forces to make sure the report
produced recommendations
unexpectedly hostile to any work
involving cloning.
In a vote late last year, MEPs
voted decisively to reject their own
report. Their decision clears the way
for the EU to put more than 200–300
million euros into stem cell research
over the next four years, as part of
its Framework 6 programme of
research throughout the Union and
other associated countries.
A European ban would have
been symbolic rather than legal, as
individual member states decide
this area of policy, but could have
been significant in future EU
funding — something over which
MEPs do have a big say.
This is a victory for
common sense and one
which proves that there
is no ethical consensus
in Europe
The vote of 316–37 against a
ban will be a relief for scientists
pursuing research into therapeutic
cloning and disappoint an army of
opponents of gene research. It
came days after a company in the
US said it had cloned a human
embryo, a move condemned by
pro-life campaigners.
One MEP sympathetic to
cloning said that more liberal
MEPs had “failed to get our act
together”, and an official said that
the end product was a “morality-
driven agenda set by Christian
Democrats, Forza Italia (the party
of Italy’s right-wing premier, Silvio
Berlusconi) and friends of the US
Republicans”. The MEP who
chaired the committee, Robert
Goebbels, was forced to admit:
“Practically everybody was
unhappy about something.
“Confusion was compounded by
the fact that 150 fewer MEPs took
part in the final vote than had
participated in the first. Euro MPs
left in droves to try to catch flights
from Brussels airport still suffering
the effects following the collapse
of the Belgian national airline,
Sabena.
The likely effect of the outcome
of the vote is that MEPs may be
encouraged to concentrate on
subjects on which they have
legislative power and avoid big
moral questions like abortion and
cloning which evoke such a
diverse range of views amongst
the Europe’s many culturally
different people. But this failure is
likely to disappoint many MEPs
who wish to express a pan-
European voice. A commission
official says that three separate
committees of the Union will
consider aspects of developments
in human genetics as it affects
their particular topics such as
health and research. 
David Bowe, the Labour MEP
on the committee, said: “This is a
victory for common sense and
one which proves that there is no
ethical consensus in Europe, and
these issues are best left to
member states. The European
parliament is going to have to
learn that it should be careful
when it steps into this area.” If
adopted in its original form, the
report could have interfered with
the EU’s plans to spend 2.15
billion euros over the next four
years on health-related genetics
research. Of this around 200-300
million euros would go to research
on aborted embryos and those left
over from in vitro fertilisation.
MEPs have voted once to back
the research programme but a
commitment to ban human
cloning would have been a
significant complication. 
During the debate in parliament,
the European Commissioner for
Research, Philippe Busquin told
MEPs: “We should not definitely
exclude particular possibilities of
research as we would thereby run
the risk of depriving ourselves of
ways of relieving great suffering
and compromising Europe’s
chance of remaining at the
forefront of knowledge.”
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